The emerging treatment of this peptide represents a exciting breakthrough in the handling of the condition. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide960994.jts-blog.com/40580394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment